Skip to main content

Advertisement

Table 2 Treatment-emergent adverse events by first occurrencea and verbatim term safety population

From: Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study

  Fish or krill Oil: 1.3 g/d
Verbatim term Treatment A Ethyl Ester (N = 22) Treatment B Triglycerides (N = 22) Treatment C krill Oil (N = 22)
Abdominal bloating 0 (0.0 %) 1 (4.5 %) 0 (0.0 %)
Abdominal cramps 0 (0.0 %) 1 (4.5 %) 0 (0.0 %)
Abdominal pain 0 (0.0 %) 0 (0.0 %) 1 (4.5 %)
Hair loss 0 (0.0 %) 0 (0.0 %) 1 (4.5 %)
Headache 0 (0.0 %) 1 (4.5 %) 1 (4.5 %)
Insect bite 1 (4.5 %) 0 (0.0 %) 0 (0.0 %)
Intermittent epistaxis 0 (0.0 %) 0 (0.0 %) 1 (4.5 %)
Intermittent vasovagal 0 (0.0 %) 0 (0.0 %) 1 (4.5 %)
Nausea 2 (9.1 %) 0 (0.0 %) 0 (0.0 %)
Total events 3 3 5
  1. aSubjects may have had more than one adverse event. For these subjects, the first occurrence of the AE was tabulated